Shilpa Medicare Announces New Joint Venture in Saudi Arabia, Shares Surge 2.45%

Mumbai, August 28, 2025 – Shilpa Medicare Limited (NSE: SHILPAMED, BSE: 530549) stock surged 2.45% to ₹836.80 during morning trading hours on Thursday. This was after the company announced a joint venture with Pharma Pharmaceutical Industries & Biological Products (PPI), a Saudi Arabia-based company, to establish a pharmaceutical manufacturing facility in Saudi Arabia.

Market Snapshot

As of 12:20, the company’s share price is currently trading at ₹833, representing a 1.14%% increase from its last closing price of ₹816.75. The stock traded between ₹822.00 and ₹849.95 today. The stock price over the past 52 weeks has fluctuated from ₹555.00 to ₹1,000.00. The company’s market capitalisation is ₹8,183.14 crore; the minimum float market capitalisation is ₹4,537.66 crore; and the adjusted P/E ratio is 69.66.

Key Trigger Behind This Surge

The rally was mainly influenced by Shilpa Medicare’s announcement that its subsidiary Koanna International FZ LLC entered into a 70:30 joint venture with PPI in Saudi Arabia. The joint venture will establish a pharmaceutical manufacturing facility in two phases: first, by supplying bulk formulations, and then transferring the technology for local manufacturing, thereby further strengthening Shilpa’s presence in the MENA region.

Outlook

The joint venture strengthens Shilpa Medicare’s market position, indicating potential for long-term growth. Investors view this positively, as it will allow Shilpa Medicare to develop its manufacturing capabilities, diversify revenue streams, and expand its global reach, which can continue to lead the company’s stock to sustained momentum.

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations